{
    "clinical_study": {
        "@rank": "117787", 
        "acronym": "ADLINE", 
        "arm_group": [
            {
                "arm_group_label": "CFAE ablation", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention: Complex fractionated atrial electrograms (CFAE) Ablation"
            }, 
            {
                "arm_group_label": "CFAE + Lines", 
                "arm_group_type": "Active Comparator", 
                "description": "CFAE Ablation followed by linear lesions (anterior and Roof line)"
            }
        ], 
        "brief_summary": {
            "textblock": "While there is a consensus to perform pulmonary vein isolation (PVI) as a cornerstone for\n      paroxysmal and persistent atrial fibrillation (AF), different additional ablation approaches\n      are used for substrate modification: linear lesions, ablation of complex fractionated atrial\n      electrograms (CFAE) or a combination of both. The aim of this study is to determine whether\n      there is a difference in terms of freedom from arrhythmia recurrence between PVI with CFAE\n      ablation in combination or not with linear lesions in patients with persistent AF."
        }, 
        "brief_title": "Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Atrial Fibrillation", 
            "Recurrence"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Recurrence"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with symptomatic persistent AF\n\n          -  After PVI +CFAE ablation, no termination into sinusrhythm or atrial tachycardia\n\n        Exclusion Criteria:\n\n          -  Left atrial thrombus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02059369", 
            "org_study_id": "GER-EP-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "CFAE ablation", 
                "description": "pulmonary vein Isolation (PVI), CFAE for substrate modification and direct current cardioversion (DCC) if AF persists", 
                "intervention_name": "PVI+CFAE+DCC", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "CFAE + Lines", 
                "description": "PVI, CFAE ablation. If AF persists linear lesions (anterior and roof line), cardioversion if AF persists", 
                "intervention_name": "PVI, CFAE, anterior and roof line, DCC", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atrial fibrillation", 
            "Recurrence", 
            "CFAE", 
            "linear ablation"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": {
            "contact": {
                "email": "ammar@dhm.mhn", 
                "last_name": "Sonia Ammar, MD", 
                "phone": "+491218", 
                "phone_ext": "2020"
            }, 
            "facility": {
                "address": {
                    "city": "Munich", 
                    "country": "Germany", 
                    "zip": "80636"
                }, 
                "name": "Deutsches Herzzentrum M\u00fcnchen"
            }, 
            "investigator": {
                "last_name": "Sonia Ammar, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation", 
        "overall_contact": {
            "email": "ammar@dhm.mhn.de", 
            "last_name": "Sonia Ammar, MD", 
            "phone": "+49891218", 
            "phone_ext": "2020"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Documented freedom from atrial arrhythmia (AF or AT) recurrence", 
            "measure": "Freedom from atrial arrhythmia", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02059369"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Duration of procedure, ablation time, fluoroscopy time and complications", 
                "measure": "Procedural and safety data", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Number of redo procedures, results and type of recurrent arrhythmia", 
                "measure": "Number and result of reablation procedure", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Deutsches Herzzentrum Muenchen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Deutsches Herzzentrum Muenchen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}